Walk with @DusetzinaS on a complicated journey of how generic #prescription #drugs are costing #Medicare beneficiaries MORE than brand-name drugs in some cases.
Read the full study in @Health_Affairs here: healthaffairs.org/doi/full/10.13…
Read the full study in @Health_Affairs here: healthaffairs.org/doi/full/10.13…
These drugs are used by older folks who have serious or rare conditions. We're talking about #cancer or #diabetes or #MS.
What the study finds is that people who pay between $20K and $80K per year for their medications pay less for brand-name drugs than generics. Weird, right?
It's due in part of how #PartD works and the economics of pharmaceuticals and, well, it's super complicated.
It's due in part of how #PartD works and the economics of pharmaceuticals and, well, it's super complicated.
Here's a chart that explains it.
Policy makers need to fix #Medicare Part D so people who use generics aren't penalized for it. @DusetzinaS and her research colleagues suggest a couple of ways to do that.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
